These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30952568)

  • 41. Personalised cooler dialysate for patients receiving maintenance haemodialysis (MyTEMP): a pragmatic, cluster-randomised trial.
    MyTEMP writing committee
    Lancet; 2022 Nov; 400(10364):1693-1703. PubMed ID: 36343653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England.
    Pierce M; Bird SM; Hickman M; Marsden J; Dunn G; Jones A; Millar T
    Addiction; 2016 Feb; 111(2):298-308. PubMed ID: 26452239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contingency Management for Patients Receiving Medication for Opioid Use Disorder: A Systematic Review and Meta-analysis.
    Bolívar HA; Klemperer EM; Coleman SRM; DeSarno M; Skelly JM; Higgins ST
    JAMA Psychiatry; 2021 Oct; 78(10):1092-1102. PubMed ID: 34347030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrated Hepatitis C-Opioid Use Disorder Care Through Facilitated Telemedicine: A Randomized Trial.
    Talal AH; Markatou M; Liu A; Perumalswami PV; Dinani AM; Tobin JN; Brown LS
    JAMA; 2024 Apr; 331(16):1369-1378. PubMed ID: 38568601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer.
    Duarte A; Walker J; Walker S; Richardson G; Holm Hansen C; Martin P; Murray G; Sculpher M; Sharpe M
    J Psychosom Res; 2015 Dec; 79(6):465-70. PubMed ID: 26652589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient-centered methadone treatment: a randomized clinical trial.
    Schwartz RP; Kelly SM; Mitchell SG; Gryczynski J; O'Grady KE; Gandhi D; Olsen Y; Jaffe JH
    Addiction; 2017 Mar; 112(3):454-464. PubMed ID: 27661788
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abstinence-contingent wage supplements to promote drug abstinence and employment: a randomised controlled trial.
    Holtyn AF; Toegel F; Subramaniam S; Jarvis BP; Leoutsakos JM; Fingerhood M; Silverman K
    J Epidemiol Community Health; 2020 May; 74(5):445-452. PubMed ID: 32086373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Acupuncture for Methadone Reduction : A Randomized Clinical Trial.
    Lu L; Chen C; Chen Y; Dong Y; Chen R; Wei X; Tao C; Li C; Wang Y; Fan B; Tang X; Xu S; He Z; Mo G; Liu Y; Gu H; Li X; Cao F; Xu H; Zhang Y; Li G; Liu X; Zeng J; Tang C; Xu N
    Ann Intern Med; 2024 Aug; 177(8):1039-1047. PubMed ID: 38976882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness and cost-effectiveness of online recorded recovery narratives in improving quality of life for people with non-psychotic mental health problems: a pragmatic randomized controlled trial.
    Slade M; Rennick-Egglestone S; Elliott RA; Newby C; Robinson C; Gavan SP; Paterson L; Ali Y; Yeo C; Glover T; Pollock K; Callard F; Priebe S; Thornicroft G; Repper J; Keppens J; Smuk M; Franklin D; Walcott R; Harrison J; Smith R; Robotham D; Bradstreet S; Gillard S; Cuijpers P; Farkas M; Zeev DB; Davidson L; Kotera Y; Roe J; Ng F; Llewellyn-Beardsley J;
    World Psychiatry; 2024 Feb; 23(1):101-112. PubMed ID: 38214639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report.
    Palis H; MacDonald S; Jun J; Oviedo-Joekes E
    Harm Reduct J; 2021 May; 18(1):57. PubMed ID: 34016137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suboxone Treatment and Recovery Trial (STAR-T): Study Protocol for a Randomised Controlled Trial of Opioid Medication Assisted Treatment with Adjunctive Medication Management Using Therapeutic Drug Monitoring and Contingency Management.
    Elarabi H; Elrasheed A; Ali A; Shawky M; Hasan N; Gawad TA; Adem A; Marsden J
    J Addict; 2019; 2019():2491063. PubMed ID: 30956839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain.
    Barry DT; Beitel M; Cutter CJ; Fiellin DA; Kerns RD; Moore BA; Oberleitner L; Madden LM; Liong C; Ginn J; Schottenfeld RS
    Drug Alcohol Depend; 2019 Jan; 194():460-467. PubMed ID: 30508769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study protocol: randomised controlled trial of conditioned open-label placebo (COLP) for perioperative pain management in patients with head and neck cancer.
    Trakimas DR; Colloca L; Fakhry C; Tan M; Khan Z; Vosler PS
    BMJ Open; 2023 Jul; 13(7):e069785. PubMed ID: 37419646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment.
    Kosten TR; Baxter LE
    Am J Addict; 2019 Feb; 28(2):55-62. PubMed ID: 30701615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High retention in an opioid agonist therapy project in Durban, South Africa: the role of best practice and social cohesion.
    Marks M; Scheibe A; Shelly S
    Harm Reduct J; 2020 Apr; 17(1):25. PubMed ID: 32295595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A patient activation intervention in primary care for patients with chronic pain on long term opioid therapy: results from a randomized control trial.
    Does MB; Adams SR; Kline-Simon AH; Marino C; Charvat-Aguilar N; Weisner CM; Rubinstein AL; Ghadiali M; Cowan P; Young-Wolff KC; Campbell CI
    BMC Health Serv Res; 2024 Jan; 24(1):112. PubMed ID: 38254073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Economic evaluation of Be a Mom, a web-based intervention to prevent postpartum depression in high-risk women alongside a randomized controlled trial.
    Monteiro F; Carona C; Antunes P; Canavarro MC; Fonseca A
    J Affect Disord; 2024 Jul; 357():163-170. PubMed ID: 38703901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost.
    Rodgers C; Siefried KJ; Ritter A; Belackova V; Treloar C; Jauncey M; Ezard N; Roberts D; Steele M; van den Brink W; Strang J; Oviedo-Joekes E; Lintzeris N; Dunlop AJ; Bell J
    BMJ Open; 2024 Aug; 14(8):e082553. PubMed ID: 39097309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of personalised telehealth intervention for chronic disease management: A pilot randomised controlled trial.
    Mudiyanselage SB; Stevens J; Toscano J; Kotowicz MA; Steinfort CL; Hayles R; Watts JJ
    PLoS One; 2023; 18(6):e0286533. PubMed ID: 37319290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study.
    Barocas JA; Savinkina A; Adams J; Jawa R; Weinstein ZM; Samet JH; Linas BP
    Lancet Public Health; 2022 Jan; 7(1):e56-e64. PubMed ID: 34861189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.